Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
Condition(s):Allergic AsthmaLast Updated:January 18, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Allergic AsthmaLast Updated:January 18, 2013Completed
Condition(s):AsthmaLast Updated:January 19, 2023Completed
Condition(s):AsthmaLast Updated:May 16, 2016Unknown status
Condition(s):CoughLast Updated:July 11, 2023Not yet recruiting
Condition(s):ASTHMA; ALLERGIC RHINITISLast Updated:March 11, 2014Unknown status
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:April 8, 2021Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:December 15, 2023Recruiting
Condition(s):AsthmaLast Updated:June 24, 2022Completed
Condition(s):BronchiolitisLast Updated:April 23, 2012Terminated
Condition(s):Allergic AsthmaLast Updated:January 19, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.